4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001367644-20-000017
EVP, Chief Financial Officer gave up 610 shares (to pay taxes)
- EVP, Chief Financial Officer acquired 12,207 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
LINDAHL RICHARD S · EVP, Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-25 | Grant or award : show line 1 in the form | +6,103 | 27,040 | D | ||
| 2020-02-25 | Grant or award : show line 2 in the form | +6,104 | 33,144 | D | ||
| 2020-02-26 | Shares withheld for taxes : show line 3 in the form | −610 | $59.91 | $36,545 | 32,534 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-25 | Grant or award : show line 4 in the form Employee Stock Options (Right to Buy) | +24,414 | $61.44 | $1,499,996 | 44,735 | D |
Loading xslF345X03/wf-form4_158285639623403.xml…